Stay updated on Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The revision stamp on the page was updated from v3.6.5 to v3.6.6, representing a minor update to the page metadata. No substantive study details, eligibility criteria, or results appear to be altered.
    Difference
    0.1%
    Check dated 2026-08-29T21:54:14.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5 instead of v3.6.4, indicating a new version of the page. No study details or layout appear to be altered.
    Difference
    0.0%
    Check dated 2026-08-08T19:25:13.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page’s revision history now shows the latest revision as v3.6.4, replacing the previous v3.6.3.
    Difference
    0.0%
    Check dated 2026-07-25T10:43:07.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3. This indicates a minor update to the study record on ClinicalTrials.gov.
    Difference
    0.0%
    Check dated 2026-07-03T22:15:39.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The page shows a newer revision identifier (v3.6.2) replacing the previous v3.6.0, indicating a minor internal update to the page rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-06-27T00:13:54.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    The page now includes a recruitment status notice indicating enrollment is closed and introduces new guidance sections for reading the study record and joining, while a header formatting tweak and revision version update are also included.
    Difference
    0.4%
    Check dated 2026-06-12T16:11:23.000Z thumbnail image

Stay in the know with updates to Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.